Arrowhead Prescription drugs Presents New Pivotal Section 3 Knowledge at ESC 2024 from PALISADE Examine of Plozasiran in Sufferers with Familial Chylomicronemia Syndrome
- Plozasiran diminished triglycerides by 80% from baseline and diminished the danger…
